Celsis IVT to Co-Market Its Hepatocytes with Promega's ADME/Tox Assays

Promega's ability to make hepatocytes is limited, so it made sense to partner with a company such as Celsis IVT that specializes in providing cells and other in vitro testing products, a Promega official said.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.